Novavax shareholder Shah Capital to step back from activist role

October 16, 2026 5:28 PM EDT

People pose with syringe with needle in front of displayed Novavax logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration

Oct 16 (Reuters) - ‌Shah Capital, ​one ​of Novavax's top shareholders, said on Friday it no longer ‌seeks to influence control of the ⁠vaccine maker after restructuring into a ‌family office.

• The investor ‌has filed with the US Securities and Exchange Commission to voluntarily withdraw ​its registration as an investment adviser, it said in a ⁠regulatory filing

• Himanshu Shah Family Office LLC has been ​established to manage the investments, the filing said

• Himanshu Shah is ​the founder, president ‌and chief investment officer of Shah Capital, Novavax's second-largest shareholder, ⁠according to LSEG data

• Shah Capital reported beneficial ownership of 10.54 million ⁠Novavax shares, or about 6.39% of the company

• ​The filing also disclosed that Shah Capital Fund LLC sold 2.87 million shares on ‌October 5 at an average price of about $11.35 apiece

• Himanshu ‌Shah reported beneficial ownership of ⁠10.66 million shares, ‌representing about 6.46% ​of Novavax

(Reporting by Sahil Pandey in Bengaluru; Editing by Shilpi ‌Majumdar)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters

Related Entities

Shah Capital